Back

Effect of baroreflex activation therapy on the clinical stability of patients with heart failure and a reduced ejection fraction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 12 Devices for Autonomic Modulation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

4 More presentations in this session

Presentation thumbnail
Is the SOFA scale a predictor of severe graft failure in the immediate post-transplant of patients with a short-medium duration circulatory assistance device?
Doctor S. Martin Paniagua (Valladolid, ES)
Abstract Slides Video
Presentation thumbnail
Improvement of knowledge and diagnostic suspicion in chronic chagas cardiopathy: results of a training program at the primary care level in mexico
Doctor L. Aguilera Mora (Guadalajara, MX)
Abstract Slides Video
Presentation thumbnail
The role of masqued anxiety and depression in the evolution of chronic heart failure disease
Associate Professor A. Noamen (Tunis, TN)
Abstract Slides Video
Presentation thumbnail
Evaluation of frailty degree by comprehensive geriatric assessment in a heart failure clinic and prognosis.
Doctor T. Roig (Badalona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 12

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Utilization of barostim in symptomatic heart failure; single center experience
thumbnail
Congress Presentation
Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up
thumbnail
Congress Presentation
Baroreflex activation therapy for severe heart failure with reduced ejection fraction: a single center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources